Charles Boustany on Corporations
Republican Representative (LA-7)
Corporate and Financial Institution Compensation Fairness Act: Amends the Securities Exchange Act to require that any proxy for an annual shareholders meeting provide for a separate shareholder vote to approve executive compensation for named executive officers. The shareholder vote shall not be:
Proponent's argument to vote Yes:Rep. BARNEY FRANK (D, MA-4): The amount of wages is irrelevant to the SEC. What this bill explicitly aims at is the practice whereby people are given bonuses that pay off if the gamble pays off, but don't lose you anything if it doesn't. That is, there is a wide consensus that this incentivizes excessive risk.
Opponent's argument to vote No:Rep. SPENCER BACHUS (R, AL-6): True, the first 6 pages of the bill give the owners, the shareholders, a non-binding vote on the pay of top executives. But then come the next 8 pages, the switch, which gives the regulators the power to decide appropriate compensation for not only just top executives but for all employees of all financial institutions above $1 billion in assets and all without regard for the shareholders' prior approval. So under the guise of empowering shareholders, it is, in fact, the government that is empowered. And, finally, on page 15, the bill designates those same government entities which regulated AIG, Countrywide, and collectively failed to prevent the worst financial calamity since the Great Depression. This bill continues the Democrat majority's tendency to go to the default solution for every problem: create a government bureaucracy to make decisions better left to private citizens and private corporations.
Proponent's argument to vote Yes:Rep. NYDIA VELÁZQUEZ (D, NY-12): We need jobs that cannot be shipped overseas and will not evaporate in the next cycle of boom and bust. But those jobs aren't going to appear out of thin air. They need to be created. By expanding existing industries and unlocking new ones, H.R. 2965 will generate the jobs we need. Job creation is the primary goal of R&D. But in order to generate new positions, we have to first develop new industries. Commercialization is critical to that process.
Opponent's argument to vote No:Rep. ED MARKEY (D, MA-7): I must oppose this bill because I have serious concerns about allowing SBIR awards to go to an unlimited number of businesses owned or controlled by venture capital (VC) firms. The SBIR program, responsible for over 60,000 patents, has always focused on innovation from truly small businesses for whom commercial capital market funding is typically not an option. However, with the change made in this bill, the SBIR program would be wide open to applicants that already are well-capitalized due to VC participation, crowding out the small businesses that have been the focus of the highly successful SBIR program.
While I support VC participation in the SBIR program, enabling an unlimited amount of large VC majority-owned firms to qualify for SBIR funding calls into question whether this program, intended for genuinely small businesses, is, in fact, still focused on these firms.
We should do everything in our power to strengthen small businesses that generate 70% of new jobs in our country. H.R 2965 does not do enough to ensure that small businesses are the focus of the SBIR program, and therefore I cannot support the bill.
Proponents support voting YES because:
We should not deprive the public, the stockholders, from being able to do anything meaningful once they find out about scandalous levels of executive compensation or board compensation. Everyone talks about the corporate board as the remedy. But the board is often a part of the problem, being paid huge amounts of money for showing up once or twice a year at meetings.
Give the stockholders a meaningful remedy. Once you get the mandatory disclosure put in place by previous legislation, we are saying the stockholders should be allowed to have a referendum on that and not have a runaround by the board.
Opponents support voting NO because:
This vote is based on mischaracterization--it is an unnecessary amendment. The opportunity for these kinds of votes already exists within the structure of corporate governance right now. A good company from Georgia, AFLAC, went ahead and already has these nonbinding shareholder votes. But there is a difference between having individuals in the private sector, shareholders and individuals outside of the mandating of government to have it occur and have government come in with its heavy hand and say, this is exactly what you need to do because we know best. Our constituents know better how to act and how to relate to corporations than Washington.
A BILL To repeal the expansion of information reporting requirements for payments of $600 or more to corporations. Section 9006 of the Patient Protection and Affordable Care Act, and the amendments made thereby, are hereby repealed; and the Internal Revenue Code of 1986 shall be applied as if such section, and amendments, had never been enacted. [This is the first attempt at dismantling ObamaCare by pieces, as opposed to H.R. 2 which dismantles ObamaCare in whole. The proposed section of the ObamaCare law to be repealed appears below. --OnTheIssues editor].
The United Food and Commercial Workers International Union (UFCW) is North America's Neighborhood Union--1.3 million members with UFCW locals in all 50 states, Puerto Rico and Canada. Our members work in supermarkets, drug stores, retail stores, meatpacking and meat processing plants, food processing plants, and manufacturing workers who make everything from fertilizer to shoes. We number over 60,000 strong with 25,000 workers in chemical production and 20,000 who work in garment and textile industries.
|Other candidates on Corporations:||Charles Boustany on other issues:|
Retiring in 2014 election:
Retired as of Jan. 2013:
Senate races 2017-8:
AL: Strange(R) ; no opponent yet
AZ: Flake(R) vs. Ward(R)
CA: Feinstein(D) vs. Eisen(D) vs. Sanchez?(D) vs. Garcetti?(D)
CT: Murphy(D) ; no opponent yet
DE: Carper(D) vs. Biden?(D) vs. Markell?(D)
FL: Nelson(D) vs. DeSantis(R) vs. Jolly(R) vs. Lopez-Cantera(R)
HI: Hirono(D) ; no opponent yet
IN: Donnelly(D) vs. Hurt(R)
MA: Warren(D) vs. Ayyadurai(R)
MD: Cardin(D) ; no opponent yet
ME: King(I) vs. LePage?(R)
MI: Stabenow(D) vs. Bouchard?(R)
MN: Klobuchar(D) vs. Paulsen?(R)
MO: McCaskill(D) vs. Kinder?(R)
MS: Wicker(R) vs. McDaniel?(R)
MT: Tester(D) vs. Racicot?(R)
ND: Heitkamp(D) vs. Becker?(R)
NE: Fischer(R) ; no opponent yet
NJ: Menendez(D) vs. Chiesa(R) vs. Codey?(D) vs. Chiesa?(R)
NM: Heinrich(D) vs. Sanchez(R)
NV: Heller(R) vs. Sandoval?(R)
NY: Gillibrand(D) vs. Kennedy?(D)
OH: Brown(D) vs. Mandel(R)
PA: Casey(D) vs. Saccone(R)
RI: Whitehouse(D) ; no opponent yet
TN: Corker(R) vs. Crim(I)
TX: Cruz(R) vs. Bush?(R)
UT: Hatch(R) vs. McMullin?(R) vs. Romney?(R)
VT: Sanders(I) vs. Giordano(D)
VA: Kaine(D) vs. Cuccinelli?(R) vs. Fiorina?(R)
WA: Cantwell(D) ; no opponent yet
WV: Manchin(D) vs. Raese(R) vs. Goodwin?(R)
WI: Baldwin(D) vs. Grothman?(R) vs. Gallagher?(R)
WY: Barrasso(R) ; no opponent yet
Senate Votes (analysis)
Email Contact Form
Longworth HOB 1117, Washington, DC 20515